Stelzer Laurie
Insider CIK 1644348 · ARNA EVP & Chief Financial Officer · HALO SVP, Chief Financial Officer · MRTX Chief Financial Officer · AGLE Director · PMVP Director · SURF Director · MBX Director · SION Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 8,026 | — | $0 | 8,026 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-01-20 | 2026-01-22 | 32,000 | — | $0 | 32,000 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2024-05-14 | 2024-05-16 | 11,323 | — | $0 | 11,323 | SEC↗ |
| AGLE Spyre Therapeutics, Inc. | A Award deriv | 2023-11-22 | 2023-11-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-08-09 | 2023-08-10 | 22,297 | $37.00 | $825.0K | 102,312 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2023-06-02 | 2023-06-02 | 4,647 | $37.06 | $172.2K | 80,015 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 45,456 | — | $0 | 45,456 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 26,864 | — | $0 | 84,662 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 91,164 | — | $0 | 91,164 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-06-01 | 2022-06-03 | 57,798 | — | $0 | 57,798 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 132,000 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 15,200 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 38,850 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2022-03-11 | 2022-03-11 | 6,660 | — | $0 | 21,462 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2022-03-11 | 2022-03-11 | 21,462 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2022-03-11 | 2022-03-11 | 9,086 | — | $0 | 28,122 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 21,462 | — | $0 | 36,366 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 17,700 | — | $0 | 17,700 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2021-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2021-03-16 | 2021-04-02 | 12,600 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | F Tax w/h | 2021-03-16 | 2021-04-02 | 4,356 | $76.10 | $331.5K | 14,904 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2021-03-16 | 2021-04-02 | 12,600 | — | $0 | 19,260 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2021-03-01 | 2021-03-03 | 15,200 | — | $0 | 15,200 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2021-03-01 | 2021-03-03 | 38,850 | — | $0 | 38,850 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2021-03-01 | 2021-03-03 | 6,660 | — | $0 | 6,660 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2020-03-16 | 2020-03-17 | 6,300 | — | $0 | 6,300 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2020-03-16 | 2020-03-17 | 132,000 | — | $0 | 132,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2020-02-22 | 2020-02-24 | 11,392 | — | $0 | 11,392 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2020-02-22 | 2020-02-24 | 11,392 | — | $0 | 120,675 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2020-02-22 | 2020-02-24 | 4,508 | $21.83 | $98.4K | 116,167 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2020-02-14 | 2020-02-18 | 7,809 | — | $0 | 15,616 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2020-02-14 | 2020-02-18 | 2,700 | $21.10 | $57.0K | 109,283 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2020-02-14 | 2020-02-18 | 7,809 | — | $0 | 111,983 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2020-02-12 | 2020-02-13 | 11,262 | — | $0 | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2020-02-12 | 2020-02-13 | 11,262 | — | $0 | 108,068 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2020-02-12 | 2020-02-13 | 3,894 | $20.00 | $77.9K | 104,174 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2020-02-10 | 2020-02-12 | 69,174 | — | $0 | 69,174 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2020-02-10 | 2020-02-12 | 32,533 | — | $0 | 32,533 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2020-02-03 | 2020-02-04 | 23,119 | — | $0 | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2020-02-03 | 2020-02-04 | 8,275 | $19.21 | $159.0K | 96,806 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2020-02-03 | 2020-02-04 | 23,119 | — | $0 | 105,081 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-06-15 | 2019-06-17 | 6,875 | — | $0 | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-06-15 | 2019-06-17 | 3,408 | $15.73 | $53.6K | 81,962 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-06-15 | 2019-06-17 | 6,875 | — | $0 | 85,370 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 12,100 | — | $0 | 12,100 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-02-22 | 2019-02-22 | 11,392 | — | $0 | 22,784 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-02-22 | 2019-02-22 | 11,392 | — | $0 | 82,434 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-02-22 | 2019-02-22 | 3,939 | $16.81 | $66.2K | 78,495 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-02-14 | 2019-02-15 | 7,809 | — | $0 | 23,425 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-02-14 | 2019-02-15 | 2,700 | $16.54 | $44.7K | 71,042 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-02-14 | 2019-02-15 | 7,809 | — | $0 | 73,742 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2019-02-12 | 2019-02-14 | 45,046 | — | $0 | 45,046 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2019-02-12 | 2019-02-14 | 85,922 | — | $0 | 85,922 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-02-03 | 2019-02-05 | 23,119 | — | $0 | 23,119 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-02-03 | 2019-02-05 | 23,119 | — | $0 | 74,250 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-02-03 | 2019-02-05 | 8,317 | $16.12 | $134.1K | 65,933 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2018-06-15 | 2018-06-18 | 6,875 | — | $0 | 6,875 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2018-06-15 | 2018-06-18 | 3,254 | $19.02 | $61.9K | 51,131 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2018-06-15 | 2018-06-18 | 6,875 | — | $0 | 54,385 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2018-02-22 | 2018-02-23 | 11,392 | — | $0 | 34,176 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2018-02-22 | 2018-02-23 | 11,392 | — | $0 | 51,449 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2018-02-22 | 2018-02-23 | 3,939 | $19.28 | $75.9K | 47,510 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2018-02-14 | 2018-02-16 | 31,234 | — | $0 | 31,234 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2018-02-14 | 2018-02-16 | 54,780 | — | $0 | 54,780 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2018-02-03 | 2018-02-05 | 23,120 | — | $0 | 46,238 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2018-02-03 | 2018-02-05 | 8,265 | $18.37 | $151.8K | 40,057 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2018-02-03 | 2018-02-05 | 23,120 | — | $0 | 48,322 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2017-06-15 | 2017-06-16 | 6,875 | — | $0 | 13,750 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2017-06-15 | 2017-06-16 | 6,875 | — | $0 | 27,785 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2017-06-15 | 2017-06-16 | 2,583 | $13.05 | $33.7K | 25,202 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 45,568 | — | $0 | 45,568 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 72,925 | — | $0 | 72,925 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2017-02-03 | 2017-02-06 | 23,120 | — | $0 | 69,358 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2017-02-03 | 2017-02-06 | 9,085 | $12.26 | $111.4K | 20,910 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2017-02-03 | 2017-02-06 | 23,120 | — | $0 | 29,995 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2016-06-15 | 2016-06-16 | 6,875 | — | $0 | 20,625 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2016-06-15 | 2016-06-16 | 6,875 | — | $0 | 16,875 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-02-03 | 2016-02-04 | 104,603 | — | $0 | 104,603 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-02-03 | 2016-02-04 | 92,478 | — | $0 | 92,478 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | P Buy | 2015-08-20 | 2015-08-24 | 10,000 | $17.24 | $172.4K | 10,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | P Buy | 2015-08-20 | 2015-08-26 | 10,000 | $17.24 | $172.4K | 10,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2015-06-15 | 2015-06-16 | 27,500 | — | $0 | 27,500 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2015-06-15 | 2015-06-16 | 225,000 | — | $0 | 225,000 | SEC↗ |